Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3346)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2022 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Díaz del Arco C, Estrada Muñoz L, Ortega Medina L, Molina Roldán E, Cerón Nieto MÁ, García Gómez de las Heras S, Fernández Aceñero MJ. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer. World J Gastrointest Oncol 2022; 14(6): 1162-1174 [PMID: 35949214 DOI: 10.4251/wjgo.v14.i6.1162] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/1162.htm |
| Number | Citing Articles |
| 1 |
Martine Perrot-Applanat, Cynthia Pimpie, Sophie Vacher, Marc Pocard, Véronique Baud. High Expression of AhR and Environmental Pollution as AhR-Linked Ligands Impact on Oncogenic Signaling Pathways in Western Patients with Gastric Cancer—A Pilot Study. Biomedicines 2024; 12(8): 1905 doi: 10.3390/biomedicines12081905
|
| 2 |
Lawrence W. Wu, Sung Joo Jang, Cameron Shapiro, Ladan Fazlollahi, Timothy C. Wang, Sandra W. Ryeom, Ryan H. Moy. Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics. Targeted Oncology 2024; 19(6): 845 doi: 10.1007/s11523-024-01097-2
|
| 3 |
Paulo Rohan, Everton Cruz dos Santos, Eliana Abdelhay, Renata Binato. High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial–Mesenchymal Transition Profile. Genes 2023; 15(1): 28 doi: 10.3390/genes15010028
|
| 4 |
Emília Rosaria Carvalho dos Santos, Marcelo Soares da Mota e Silva, Nathalie Henriques Silva Canedo, Maria de Fatima Dias Gaui, Álvaro Luiz Vieira Lubambo de Britto, William Marco Vicente da Silva, Maria da Glória da Costa Carvalho, Guilherme Pinto Bravo Neto. Epstein-Barr virus in gastric cancer and association with 30 bp del-latent membrane protein 1 polymorphism. Revista da Associação Médica Brasileira 2023; 69(5) doi: 10.1590/1806-9282.20221571
|
| 5 |
Juan Zhang, Chao Su, Yuyang Zhang, Rongji Gao, Xiaomei Lu, Jing Liang, Haiwei Liu, Song Tian, Yitao Zhang, Zhaoxiang Ye. Spectral CT-based nomogram for preoperative prediction of Lauren classification in locally advanced gastric cancer: a prospective study. European Radiology 2024; doi: 10.1007/s00330-024-11163-y
|
| 6 |
Cristina Díaz del Arco, M Jesús Fernández Aceñero, Luis Ortega Medina. Liquid biopsy for gastric cancer: Techniques, applications, and future directions. World Journal of Gastroenterology 2024; 30(12): 1680-1705 doi: 10.3748/wjg.v30.i12.1680
Abstract(390) |
Core Tip(394) |
Full Article(HTML)(3300)
|
Full Article with Cover (PDF)-3511K(150)
|
Audio-946K(1)
|
Peer-Review Report-332K(44)
|
Answering Reviewers-92K(38)
|
Supplementary Material-1013K(44)
|
Full Article (PDF)-3338K(146)
|
Full Article (XML)-463K(39)
|
Times Cited (1)
|
Total Visits (6037)
|
Open
|
| 7 |
Xueqing Yin, Xinzhong Ruan, Yongmeng Zhu, Yongfang Yin, Rui Huang, Chao Liang. Prediction of peritoneal free cancer cells in gastric cancer patients by golden-angle radial sampling dynamic contrast-enhanced magnetic resonance imaging. Journal of Zhejiang University-SCIENCE B 2024; 25(7): 617 doi: 10.1631/jzus.B2300929
|
| 8 |
Ke Wang, Yuanyuan Yu, Jian Zhao, Qianhao Meng, Chang Xu, Jing Ren, Yanqiao Zhang, Yusheng Wang, Guangyu Wang. A Retrospective Analysis of the Lauren Classification in the Choice of
XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer. Current Gene Therapy 2024; 24(2): 147 doi: 10.2174/0115665232247694230921060213
|